UNSPSC 51281812: Zorubicin

This classification denotes an anthracycline antibiotic with the molecular formula C34H35N3O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V25F9362OP, chemically known as rp-22,050 hydrochloride but generally known as zorubicin, which bears US NIH Compound Identifier 6540456. European Medicines Agency schedules Zorubicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00190MIG.

UNSPSC 51281812 Zorubicin is a Commodity code that appears to designate a specific pharmaceutical product, yet the most recent state and local opportunities tagged under it show little relevant activity. The Illinois Department of Public Health awarded a completed pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, but that award covered Doxycycline Hyclate and Ciprofloxacin Hydrochloride, not Zorubicin. Seminole County, Florida released an IFB on June 30, 2026 for Naloxone and Safe Drug Deactivation Systems, which is likewise unrelated to the code's nominal scope. The mismatch between the code designation and the actual products being solicited suggests either a data-tagging error or that Zorubicin procurement does not currently appear in state and local opportunities tracked in the available records.

No open solicitations for Zorubicin itself appear in recent state and local procurement activity. Business development professionals should verify whether this code reflects actual procurement demand before committing resources to pursue it. If Zorubicin does move into state and local procurement channels, the entry points will likely mirror the pharmaceutical warehouse and public health purchasing patterns shown by Illinois's department-level cooperative purchasing and Seminole County's direct health procurement, but current signal from the market is minimal.